Company Search:
Advanced Search
Sponsored Links
Pharmaxis Ltd Company Snapshot
Pharmaxis Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other companies in this sector in Australia: Anteo Diagnostics Limited (2016 sales of 12.67 million Australian Dollars [US$9.79 million] ), Xrf Scientific Ltd (21.13 million Australian Dollars [US$16.32 million] of which 43% was Precious Metals), and Idt Australia Limited. (16.91 million Australian Dollars [US$13.06 million] of which 55% was CMAX).

Sales Analysis. Sales fell dramatically in 2016: During the year ended June of 2016, sales at Pharmaxis Ltd were A$18.57 million (US$14.34 million). This is a sharp decrease of 68.3% versus 2015, when the company's sales were A$58.63 million. Contributing to the drop in overall sales was the 93.6% decline in New Drug Development, from A$40.60 million to A$2.58 million. There were also decreases in sales in Bronchitol and Aridol (down 15.0% to A$14.91 million) and Corporate (down 17.0% to A$317,000.00 ) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pharmaxis Ltd
  Stock Performance Chart for Pharmaxis Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): .26
(Figures in Australian Dollars)
1 Week -3.7%   13 Weeks -1.9%  
4 Weeks -7.1%   52 Weeks 13.0%  
Pharmaxis Ltd Key Data:
  Ticker: PXS Country: Australia
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 18,573,000
(Year Ending Jan 2017).
Employees: 107
  Currency: Australian Dollars Market Cap: 82,460,159
  Fiscal Yr Ends: June Shares Outstanding: 317,154,457
  Share Type: Ordinary Closely Held Shares: 45,692,109
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.